DrugPatentWatch Database Preview
Enalapril maleate - Generic Drug Details
What are the generic drug sources for enalapril maleate and what is the scope of enalapril maleate patent protection?
Enalapril maleate
is the generic ingredient in seven branded drugs marketed by Silvergate Pharms, Apotex, Apothecon, Ivax Sub Teva Pharms, Krka Dd Novo Mesto, Mylan, Sandoz, Sandoz Inc, Sun Pharm Inds Ltd, Taro, Teva, Watson Labs, Wockhardt Ltd, Valeant Pharms North, Astrazeneca, Apotex Inc, Dr Reddys Labs Ltd, G And W Labs Inc, Taro Pharm Inds, Upsher-smith Labs, and Valeant Intl, and is included in twenty-eight NDAs. There are seven patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.There are twenty-seven drug master file entries for enalapril maleate. Forty-one suppliers are listed for this compound.
Summary for enalapril maleate
| US Patents: | 7 |
| Tradenames: | 7 |
| Applicants: | 21 |
| NDAs: | 28 |
| Drug Master File Entries: | 27 |
| Suppliers / Packagers: | 41 |
| Bulk Api Vendors: | 53 |
| Clinical Trials: | 13 |
| Patent Applications: | 3,459 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for enalapril maleate |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for enalapril maleate |
| DailyMed Link: | enalapril maleate at DailyMed |
Pharmacology for enalapril maleate
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
Medical Subject Heading (MeSH) Categories for enalapril maleate
Synonyms for enalapril maleate
| ((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline |
| (2S)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic aci |
| (2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid; maleic acid |
| (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| (2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid |
| (S,S,S)-1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| (S,S,S)-Enalapril Maleate |
| (S)-(-)-1-[N-(1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl]-Lproline |
| (S)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid |
| (S)-1-((S)-2-((R)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid |
| (S)-1-((S)-2-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID MALEATE |
| (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline |
| (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline maleate |
| (S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline maleate (1:1) |
| (S)-1-[(R)-2-((R)-1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| (S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-AL |
| (S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE |
| (S)-1-[N-[1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE MALEATE |
| (S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid |
| (S)-N-[1-(Ethoxycarbonyl)-3-phenylpropyl]-Ala-Pro maleate salt |
| (SSS)1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| (Z)-but-2-enedioic acid; (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| (Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
| 095E164 |
| 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester |
| 1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester, maleate (1:1) |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid (Enalapril) |
| 1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(enalapril) |
| 1-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-L-proline Maleate |
| 172964-46-4 |
| 2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid(enalapril) |
| 69PN84IO1A |
| 75847-73-3 |
| 75847-73-3 (Parent) |
| 76095-16-4 |
| 76095-16-4 (maleate) |
| 76420-75-2 |
| 77549-58-7 |
| 77549-59-8 |
| 847E733 |
| 9O25354EPJ |
| A-Rin |
| AB00053615_19 |
| AB00053615_20 |
| AB00053615-17 |
| AB00053615-18 |
| AB0013100 |
| AB03713 |
| AB2000386 |
| AC1NTUS2 |
| AC1NTUS5 |
| Acetensil |
| AK325516 |
| AK486954 |
| AKOS016340376 |
| AKOS025310615 |
| Alphrin |
| Amprace |
| AN-15422 |
| analapril |
| Analept |
| AOB5651 |
| API0002541 |
| Atens |
| Baripril |
| BDBM50017129 |
| Benalapril |
| Benalipril |
| BIDD:GT0751 |
| Biocronil |
| BPBio1_000340 |
| BQL |
| BSPBio_000308 |
| BSPBio_003035 |
| C-21264 |
| C06977 |
| C20H28N2O5 |
| C20H28N2O5.C4H4O4 |
| CAS-75847-73-3 |
| CAS-76095-16-4 |
| CC-27456 |
| CCG-39221 |
| CHEBI:4784 |
| CHEBI:4785 |
| CHEMBL1200659 |
| CHEMBL578 |
| Controlvas |
| Converten |
| Convertin |
| Coprilor |
| Coroldil |
| CPD001906771 |
| Crinoren |
| CS-2373 |
| CS-2918 |
| CTK8F9436 |
| D00621 |
| D00SEB |
| D07892 |
| Dabonal |
| DB00584 |
| Defluin |
| Denapril |
| Ditensor |
| DivK1c_000408 |
| DR002110 |
| DSSTox_CID_2982 |
| DSSTox_GSID_22982 |
| DSSTox_RID_76817 |
| DTXSID5022982 |
| Ecapril |
| Ednit |
| Ednyt |
| EINECS 278-375-7 |
| EINECS 278-460-9 |
| Elfonal |
| Enacard |
| Enalabene |
| Enaladex |
| Enaladil |
| enalapril |
| Enalapril (INN) |
| Enalapril (maleate) |
| Enalapril (TN) |
| Enalapril [INN:BAN] |
| ENALAPRIL 2-BUTENEDIOATE |
| enalapril hydrogen maleate |
| Enalapril maleate (JP17/USP) |
| Enalapril maleate (Vasotec) |
| Enalapril maleate [USAN:JAN] |
| Enalapril maleate [USAN:USP:JAN] |
| Enalapril maleate salt |
| Enalapril Maleate Usp Xxi |
| Enalapril Richet |
| Enalapril, AldrichCPR |
| Enalaprila |
| Enalaprila [INN-Spanish] |
| Enalaprilmaleate |
| Enalaprilum |
| Enalaprilum [INN-Latin] |
| Enalasyn |
| Enaloc |
| Enalped |
| Enap |
| Enapren |
| Enapres |
| Enapril |
| Enaprin |
| Enarenal |
| Enaril |
| Envas |
| Epaned |
| Epaned Kit |
| Eupressin |
| Feliberal |
| GBXSMTUPTTWBMN-XIRDDKMYSA-N |
| Glioten |
| Glioten;Renitec;Vasotec |
| GTPL6322 |
| H531 |
| HE386417 |
| Herten |
| Hipoartel |
| Hipten |
| HMS1921B10 |
| HMS2090E08 |
| HMS2092L17 |
| HMS2095P10 |
| HMS2231D22 |
| HMS2232I24 |
| HMS501E10 |
| HSDB 6529 |
| HY-B0331 |
| HY-B0331A |
| Hytrol |
| I04-153 |
| IDI1_000408 |
| Innovace |
| Innovace Melt |
| Innovade |
| Inoprilat |
| Insup |
| Invoril |
| J10412 |
| K298 |
| KBio1_000408 |
| KBio2_001787 |
| KBio2_004355 |
| KBio2_006923 |
| KBio3_002535 |
| KBioGR_000355 |
| KBioSS_001787 |
| Kenopril |
| KM1738 |
| Konveril |
| KS-1137 |
| L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)- |
| L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-, (Z)-2-butenedioate (1:1) |
| L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl- |
| L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-, (2Z)-2-butenedioate (1:1) |
| L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl- |
| Lapril |
| Lipraken |
| Lotrial |
| LS-118938 |
| LS-190651 |
| Mapryl |
| Mepril |
| MFCD00133304 |
| MFCD00865774 |
| Minipril |
| MK 421 |
| MK 421 maleate |
| MK-421 |
| MLS000028657 |
| MLS001077272 |
| MLS006010047 |
| MolPort-002-885-877 |
| MolPort-003-666-389 |
| N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate (1:1) |
| N-(1 (S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate |
| N-(1(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline |
| N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate |
| N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline |
| N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline (2Z)-but-2-enedioate |
| N-[(S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE MALEATE(1: 1) |
| N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline |
| N-[1(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline maleic acid salt |
| N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline |
| N-{N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl}-L-proline hydrogen maleate |
| Nalpha -[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline |
| Naprilene |
| Naritec |
| NCGC00016932-01 |
| NCGC00021569-04 |
| NCGC00021569-05 |
| NCGC00021569-06 |
| NCGC00021569-09 |
| Neotensin |
| NINDS_000408 |
| Norpril |
| NSC-758143 |
| NSC758143 |
| Nuril |
| Opera_ID_1793 |
| OYFJQPXVCSSHAI-QFPUQLAESA-N |
| Palane |
| Pharmakon1600-01501214 |
| Pres |
| Presil |
| Pressotec |
| Prestwick_197 |
| Prestwick3_000314 |
| Pril |
| Prilenap |
| PRO106 |
| Pulsol |
| Reca |
| Regomed |
| Renavace |
| Renitec |
| Reniten |
| Renivace |
| Renivace (TN) |
| Repantril |
| Ristalen |
| s1941 |
| SAM002564252 |
| SBI-0051691.P002 |
| SC-17520 |
| SC-76440 |
| SCHEMBL18 |
| SCHEMBL9 |
| Sintec |
| SMR000058883 |
| SMR000653477 |
| SPBio_001349 |
| Spectrum_001307 |
| SPECTRUM1501214 |
| Spectrum2_001455 |
| Spectrum3_001478 |
| Spectrum4_000008 |
| Spectrum5_001107 |
| SR-01000000234 |
| SR-01000000234-4 |
| ST51052621 |
| Tenace |
| Tensazol |
| Tox21_110872 |
| Tox21_110872_1 |
| Unaril |
| UNII-69PN84IO1A |
| UNII-9O25354EPJ |
| Vapresan |
| Vasopril |
| Vasotec |
| Xanef |
| ZINC3791297 |
US Patents and Regulatory Information for enalapril maleate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075048-003 | Aug 22, 2000 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Upsher-smith Labs | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 076116-001 | Sep 19, 2001 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sandoz Inc | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075496-002 | Aug 22, 2000 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Sandoz | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075048-001 | Aug 22, 2000 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Watson Labs | ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 075501-001 | Aug 22, 2000 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for enalapril maleate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-005 | Jul 26, 1988 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-003 | Dec 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-002 | Dec 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Valeant Pharms North | VASOTEC | enalapril maleate | TABLET;ORAL | 018998-001 | Dec 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for enalapril maleate
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014055667 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2017161339 | ➤ Try a Free Trial |
| Brazil | 112015007592 | ➤ Try a Free Trial |
| European Patent Office | 2903690 | ➤ Try a Free Trial |
| Canada | 2887379 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: